Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Orthop Res. 2011 Sep 12;30(4):547–553. doi: 10.1002/jor.21548

Figure 4.

Figure 4

Ratio of bioluminescence signal from operated (infusion of UHWMPE particles) femora divided by the corresponding non-operated contralateral femora from Day 0 to 19 post reporter cell injection using RAW cells. The ratio was significantly lower when the MCP-1 receptor antagonist (RS102895) was given.